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Abstract
Presenilin (PS) is involved in many cellular events under physiological and pathological conditions. Previous reports have
revealed that PS deficiency results in hyperproliferation and resistance to apoptotic cell death. In the present study, we
investigated the effects of PS on b-catenin and cell mortality during serum deprivation. Under these conditions, PS1/PS2
double-knockout MEFs showed aberrant accumulation of phospho-b-catenin, higher ROS generation, and notable cell
death. Inhibition of b-catenin phosphorylation by LiCl reversed ROS generation and cell death in PS deficient cells. In
addition, the K19/49R mutant form of b-catenin, which undergoes normal phosphorylation but not ubiquitination, induced
cytotoxicity, while the phosphorylation deficient S37A b-catenin mutant failed to induce cytotoxicity. These results indicate
that aberrant accumulation of phospho-b-catenin underlies ROS-mediated cell death in the absence of PS. We propose that
the regulation of b-catenin is useful for identifying therapeutic targets of hyperproliferative diseases and other degenerative
conditions.
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Introduction
b-catenin is a multifunctional protein that forms an adhesion
complex with E-cadherin, a-catenin, and actin; it also plays a
central role in Wnt signaling through its nuclear translocation and
association with T-cell factor (TCF) and lymphoid enhancer factor
(LEF) [1,2]. Cytosolic b-catenin is tightly regulated by interactions
with several proteins, such as adenomatous polyposis coli (APC),
glycogen synthase kinase-3b (GSK-3b), and axin [3,4]. b-catenin is
sequentially phosphorylated at serine 45 by casein kinase-1 (CK-1)
and at threonine 41, serine 37, and serine 33 by GSK-3b.
Phosphorylated b-catenin is recognized by b-transducin repeat-
containing protein (b-TrCP) E3 ligase, which targets it for
degradation by ubiquitin-proteasomal machinery [5–7].
Presenilin (PS) is a multipass membrane protein that regulates
many physiological and pathological processes. Mutations in two
PS genes, PS1 and PS2, cause familial Alzheimer disease (FAD)
and elevate levels of the longer form of amyloid b-peptide (Ab),
which is derived from amyloid precursor protein (APP) [8,9]. PS is
the catalytic subunit of the c-secretase complex that cleaves many
type 1 membrane proteins. Besides its activity in the c-secretase
complex, PS has effects on various intracellular activities, such as
Wnt/b-catenin signaling, phosphatidylinositol 3-kinase/Akt and
MEK/ERK signaling, calcium homeostasis, and apoptosis [10–
14]. PS1-null mice are embryonic lethal and exhibit skeletal and
central nervous system (CNS) defects [15]. Studies of mouse
embryonic fibroblasts (MEFs) from PS1-null mice and skin of adult
PS1 conditional knockout mice, however, show that PS1
deficiency elicits tumor-like phenomena at least in part through
stabilization of b-catenin and epidermal growth factor receptor
(EGFR) [10,16,17]. In addition, PS deficiency and inhibition of c-
secretase activity cause resistance to apoptotic stimuli [14,18].
In the present study, we identified a novel function of
phosphorylated b-catenin in the absence of PS. Phosphorylated
b-catenin accumulated abnormally in PS-deficient MEFs under
conditions of serum deprivation, provoking reactive oxygen species
(ROS) generation and ROS-induced cell death.
Results
PS dKO MEFs are vulnerable to serum deprivation-
induced cell death
Although we confirmed protein expression of PS1 and nicastrin
in crude extracts of PS WT and human PS1-rescued PS dKO
(hPS1) MEFs, PS was not detected in PS dKO MEFs, as
previously reported [19]. Immature form of nicastrin was detected
in PS dKO cells as expected. Exogenous human PS1, however,
recovered the PS1-CTF band and maturation of nicastrin
(Figure 1A). To examine the role of PS in cell survival, conditions
of serum deprivation were applied to each cell type. By LDH
release assay, PS dKO MEFs were more vulnerable to serum
deprivation than PS WT cells (p,0.001, Figure 1B). Restoration
of hPS1 in PS dKO MEF decreased this vulnerability and
restored the rate of cell death to PS WT levels (p,0.001,
Figure 1B).
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To determine the mechanism that underlies serum deprivation-
induced cell death in PS dKO MEFs, we examined ROS
generation in these MEFs by fluorescence microscopy using the
DCFDA fluorophore. After 36 hr in DMEM, PS dKO MEFs
generated high levels of ROS, as evidenced by damaged
morphology with DCFDA staining (Figure 2A). Unlike PS dKO
MEFs, PS WT and hPS1 MEFs had healthier cell morphologies,
exhibiting lower DCFDA signals (Figure 2A). We also assessed the
effects of trolox, a water-soluble derivative of vitamin E, as an
antioxidant and LiCl, a widely used GSK-3 inhibitor, on stress
from serum deprivation. Trolox and LiCl treatment protected PS
dKO MEFs against serum deprivation-induced cell death
(p,0.001, Figure 2B) and inhibited ROS generation (Figure 2A).
Phospho-b-catenin accumulates in PS dKO MEFs under
serum deprivation
We examined b-catenin protein levels in PS dKO MEFs
because PS interacts with b-catenin [20]. By Western blot, we
observed higher levels of b-catenin in PS dKO MEFs, but b-
catenin levels in hPS1 MEFs and PS WT MEFs were comparable
in basal condition (Figure 3A). Based on our results that LiCl
treatment protected PS dKO MEFs against serum deprivation
induced-ROS generation and cell death (Figure 2A and 2B,
respectively), we investigated the effect of GSK-3b on b-catenin
phosphorylation. By immunofluorescence using a specific antibody
for phospho-b-catenin (S33, S37, and T41), we detected robust
phospho-b-catenin signals in PS dKO MEFs under conditions of
serum deprivation, but PS WT MEFs in either growth or serum-
deprived media and PS dKO MEFs in growth media showed little
fluorescence (Figure 3B). In PS dKO MEFs, GSK-3b inhibition
with LiCl reduced phospho-b-catenin levels (S33, S37, T41), but
trolox did not (Figure 3C), as confirmed by Western blot
(Figure 3D).
Accumulation of phospho-b-catenin induces cytotoxicity
in H4 neuroglioma cells
To examine whether accumulated phospho-b-catenin affects
cell viability, we introduced several b-catenin constructs into H4
neuroglioma cells. After transient transfection with each construct,
we measured protein expression from these constructs in H4 cells.
To induce phospho-b-catenin accumulation, the K19/49R
mutant construct was transfected, because this mutant fails to
undergo ubiquitination and degradation due to their mutated
ubiquitination site [7]. By Western blot, levels of the phosphor-
ylated form of b-catenin (on residues 33, 37, and 41) were high in
K19/49R b-catenin mutant transfectants (Figure 4A), suggesting
that phospho-b-catenin accumulated in the cells. In contrast, the
S37A b-catenin mutant induced the highest levels of total b-
catenin but showed low reactivity by immunoblotting with anti-
phospho-b-catenin (Figure 4A). Endogenous b-catenin and b-actin
in each transfectant cell type were expressed similarly. Using these
constructs, we performed the LDH release assay to measure cell
viability under conditions of serum deprivation. K19/49R b-
catenin mutant-transfected H4 cells had increased rates of cell
death compared with WT b-catenin-transfected cells (p,0.005,
Figure 4B); S37A b-catenin-transfected H4 cells, however, had
greater viability compared with WT b-catenin transfectants
(p,0.05, Figure 4B). To determine the effects of phospho-b-
catenin on ROS generation, we stained H4 cells with DCFDA.
Similar to the results of the LDH release assay, most K19/49R b-
catenin transfectants were brightly stained, although only few cells
remained (Figure 4C). WT b-catenin and S37A b-catenin
Figure 1. PS dKO MEFs are vulnerable to serum deprivation-induced cell death. (A) Western blot analysis of nicastrin and PS1 showing that
PS dKO MEFs prevent nicastrin maturation. hPS1 MEFs were rescued PS1 and nicastrin maturation. Calnexin served as a loading control for membrane
fractions. Filled and blank arrows indicate mature and immature nicastrin, respectively. Filled and blank arrowheads indicate full-length PS1 and PS1-
CTF, respectively. (B) LDH release assay showing that PS dKO MEFs are injured by serum deprivation-induced stress. All MEFs were incubated DMEM
media without serum for 36 hr. The graph represents (%) of positive control. Data are means6SEM values of three independent experiments.
* represents significant differences from PS WT MEFs. ***P,0.001. # represents significant differences from PS dKO MEFs. ###P,0.001.
doi:10.1371/journal.pone.0004172.g001
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transfectants (Figure 4C), suggesting that accumulation of
phospho-b-catenin induces ROS generation.
Discussion
PS performs many functions in such physiological and
pathological processes as development, calcium signaling, apopto-
sis, and Alzheimer disease. Previous studies demonstrated that b-
catenin accumulation occurs in the absence of PS, which is
accompanied by increased proliferation [16,17]; these results were
recapitulated in our experiments in which PS dKO MEFs
experienced an accumulation in b-catenin (Figure 3A) and
increased proliferation (data not shown) in normal growth media.
In contrast, several reports have shown that b-catenin suppresses
growth and induces cytotoxicity [21–23]. Here, we examined cell
mortality and b-catenin expression under conditions of serum
deprivation in the absence of PS. Because PS dKO MEFs died
easily on removal of serum compared with PS WT MEFs, we
determined whether PS was associated with this phenomenon
using hPS1-supplied MEFs. Reconstitution of human PS1 in PS
dKO MEFs reversed the vulnerability to serum deprivation-
induced cell death, suggesting that PS1 is protective under such
circumstances.
To identify the underlying mechanism of these phenomena,
intracellular ROS levels were measured, because ROS are formed
during serum deprivation-induced cell death [24], although there
has been no report that links between b-catenin and ROS
generation. Many cells were stained brightly with DCFDA in PS
dKO MEFs during serum deprivation, but PS-containing MEFs
and LiCl- and trolox-treated PS dKO MEFs experienced reduced
fluorescent intensity and cell death. When PS dKO MEFs were
deprived of serum, they accumulated more phospho-b-catenin,
generated more ROS, and died at higher rates than PS WT MEFs
or hPS1 MEFs. Treatment with the antioxidant trolox inhibited
ROS generation and serum deprivation-induced cell death in PS
dKO MEFs (Figure 2A & B), but it could not block phospho-b-
catenin levels (Figure 3C & D). Treatment with LiCl, a potent
inhibitor that blocks the phosphorylation of b-catenin by GSK-3b,
reduced phospho-b-catenin levels, ROS generation, and serum
deprivation-induced cell death in PS dKO MEFs (Figures 2A & B
and Figures 3C & D). These results suggest that accumulation of
phospho-b-catenin causes the generation of ROS and cell death in
serum-deprived PS dKO MEFs. To assess the cytotoxic effect of
GSK-3b-induced phospho-b-catenin, we transiently transfected
H4 neuroglioma cells with wild-type and mutant b-catenin
constructs. Because b-catenin undergoes sequential processing,
including phosphorylation, ubiquitination, and degradation, we
designed an experiment with various b-catenin mutants, in which
we substituted serine for alanine at position 37. This mutation
inhibited GSK-3b-mediated phosphorylation of b-catenin, cur-
tailing subsequent ubiquitination and proteosomal degradation.
Substitution of lysine with arginine at positions 19 and 49 inhibited
ubiquitination of b-catenin and degradation as well. Western blot
analysis with anti-phospho-b-catenin (S33, 37, T41) demonstrated
that the K19/49R b-catenin mutant had the highest immunore-
activity, as expected. The S37A b-catenin mutant was robustly
detected by an anti-b-catenin antibody that recognized the total
Figure 2. ROS-mediated serum deprivation-induced cell death in PS dKO MEFs. (A) ROS generation of MEFs was detected using the DCFDA
fluorophore. All MEFs were incubated in DMEM w/wo 200 mM trolox or 10 mM LiCl for 36 hr. PS dKO MEFs showed higher signal intensities, but
hPS1-rescued MEFs and trolox- or LiCl -treated PS dKO MEFs had lower signals. The white bar represents 50 mm. (B) PS dKO MEFs were incubated in
the presence or absence of 200 mM trolox or 10 mM LiCl in DMEM for 36 hr. LDH release assay showed that both trolox and LiCl efficiently protected
against serum deprivation-induced cell death. The graph represents (%) of positive control. Data are means6SEM values of three independent
experiments. * represents significant differences from untreated PS dKO MEFs. ***P,0.001.
doi:10.1371/journal.pone.0004172.g002
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mediated phospho-b-catenin antibody. This mutant was well
labeled by anti-phospho-b-catenin (T41, S45), as expected (data
not shown). In contrast, because exogenous WT b-catenin also was
regulated by endogenous machinery, little exogenous WT b-
catenin remained in the b-catenin mutants. In the LDH release
assay, K19/49R b-catenin mutant-transfected H4 cells had higher
rates of cell death and ROS generation than transfectants of other
mutants. S37A b-catenin-transfected H4 cells experienced less
death and ROS generation than wild-type b-catenin transfectants,
despite higher total levels of b-catenin in S37A b-catenin mutant
transfectants than in K19/49R b-catenin transfectants and wild-
type cells (Figure 4). These results imply that increases in b-catenin
are not essential in generating ROS or inducing cell death under
conditions of serum deprivation. Only accumulation of phospho-
b-catenin is responsible for ROS generation and the ensuing cell
death. This is the first report that demonstrates that accumulation
of phospho-b-catenin generates ROS and leads to cell death in a
Figure 3. Phospho-b-catenin was accumulated in PS dKO MEFs under serum deprivation conditions. (A) b-catenin was accumulated in
PS dKO MEFs, not in PS WT under normal and serum deprivation conditions. b-actin served as a loading control. (B) PS WT and PS dKO MEFs were
incubated in growth media or DMEM for 30 hr, followed by immunofluorescent staining. PS dKO MEFs in DMEM labeled more brightly against anti-
phospho-b-catenin (S33, 37, T41) antibody. The white bar represents 200 mm. (C) PS dKO MEFs were incubated w/wo 10 mM LiCl or 200 mM trolox in
DMEM for 30 hr and labeled with phospho-b-catenin (S33, 37, T41)-specific antibody (Red). Many cells contained phosphorylated forms of b-catenin
in DMEM- and trolox-treated PS dKO MEFs by fluorescence microscopy. But, LiCl-treated PS dKO MEFs stained weakly. DAPI staining was used to
visualize cell nuclei (Blue). The white bar represents 200 mm. (D) Western blot analysis showed that LiCl effectively decreased phosphorylation of b-
catenin at the S33, 37, and T41 sites without altering total b-catenin or b-actin levels. However, trolox-treated cells showed similar levels of phospho-
b-catenin compared with DMEM alone.
doi:10.1371/journal.pone.0004172.g003
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is more toxic. It maybe phosphorylation changes the conformation
of b-catenin such that it may interact with proteins in a different
way or inhibits the E3 ligase machinery. Or, it may not be the
phosphorylation per se, but the activity of GSK-3, b-TrCP E3
ligase, or proteasome [25–27]. We checked whether c-secretase
inhibitor can mimic the increased vulnerability to serum
withdrawal using PS expressing cells. Since c-secretase inhibitor
did not affect vulnerability of the cells, we can rule out
intramembrane proteolysis, and b-catenin is not regulated by c-
secretase inhibitor under serum deprivation condition. One other
point is why serum deprivation preferentially increases b-catenin
phosphorylation in the absence of PS. Under normal basal
conditions, we previously showed that PS facilitates b-catenin
phosphorylation via a scaffolding mechanism (bringing b-catenin
and GSK-3 in complex with PS). At the same time, generalized
GSK-3 activity (as detected by phospho-GSK3) is increased in PS
dKO cells. Serum withdrawal should further enhance general
GSK-3 activity in all cells because of lack of growth factor, etc. and
loss of PI3K/Akt signaling [28,29]. But perhaps under conditions
of prolonged serum withdrawal (36 hrs), GSK-3 activity, localiza-
tion, etc may be altered (i.e. directed at tau for example) such that
PS1 still sequesters b-catenin but cannot bring together GSK-3. If
so, then the loss of PS may indirectly promote GSK-3 mediated
phosphorylation of b-catenin by neither sequestering b-catenin
nor GSK-3. These points are needed to be clarified by further
study.
Taken together, b-catenin facilitates cell proliferation under
normal growth conditions, but when serum is limited, phosphor-
ylated b-catenin accumulates in the absence of PS and induces
ROS generation and cell death.
Materials and Methods
Cell culture and transfection
Wild-type (PS+/+) MEFs (PS WT MEFs), PS double knockout
(PS2/2; ie, doubly deficient for PS1 and PS2) MEFs (PS dKO
MEFs) (a kind gift from Dr. Bart De Strooper, Katholieke
Universiteit Leuven, Leuven, Belgium), and PS2/2 MEFs that
stably expressed human wild-type PS1 (hPS1) (hPS1 MEFs) were
maintained according to previous reports [13,30,31]. Briefly, the
human neuroglioma cell line H4 and all MEFs were maintained in
Dulbecco’s modified Eagle’s medium (DMEM; HyClone, Salt
Lake City, Utah) supplemented with 10% fetal bovine serum (FBS;
HyClone) and 0.1 mg/ml penicillin and streptomycin (Sigma, St
Louis, MO) at 37uC in a 5% CO2 incubator. Transient
transfection was performed using LipofectAMINE LTX (Invitro-
gen, Carlsbad, CA) according to the instructions provided by the
manufacturer.
Figure 4. Accumulation of phospho-b-catenin induces cytotoxicity in H4 neuroglioma cells. (A) H4 cells were transiently transfected with
EYFP vector, WT, and mutant b-catenin constructs in DMEM for 16 hr. K19/49R b-catenin-transfected cells showed higher immunoreactivity against
anti-phospho-b-catenin (S33, 37, T41) without affecting endogenous b-catenin and b-actin levels. Filled and blank arrows indicate exogenous b-
catenin-EYFP fusion protein and endogenous b-catenin, respectively. Arrowhead indicates nonspecific bands. (B) LDH release assay showed that K19/
49R b-catenin induced cytotoxicity in the transfectants. The graph represents (%) of positive control. Data are means6SEM values of three
independent experiments. * represents significant differences from EYFP vector-transfected H4 cells. *P,0.05, **P,0.01, ***P,0.001. # represents
significant differences from WT b-catenin-EYFP-transfected H4 cells. ###P,0.001. (C) DCFDA staining showing ROS generation of mock and b-
catenin-transfected H4 cells. Although fewer cells remained among K19/49R b-catenin tranfectants, the DCFDA signal was much higher than in other
transfectants. The white bar represents 200 mm.
doi:10.1371/journal.pone.0004172.g004
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Wild-type b-catenin (a kind gift form Dr. CY Choi,
Sungkyunkwan University, Korea), and each mutant (S37A,
S45A, or K19/49R) in mock and EYFP vectors were transfected
into H4 cells. The following antibodies were used: mouse
monoclonal anti-b-catenin (Transduction Laboratories, BD Bio-
sciences, San Jose, CA); rabbit polyclonal anti-phospho-b-catenin
(Ser33/37/Thr41), rabbit polyclonal anti-phospho-b-catenin
(Thr41/Ser45), and rabbit polyclonal anti-calnexin (Cell Signal-
ing, Beverly, MA); mouse monoclonal anti-nicastrin, and mouse
monoclonal anti-PS1 loop (Chemicon, Temecula, CA); and mouse
monoclonal anti-b-actin (Sigma).
Cell viability assay
Dead and membrane-ruptured cells were quantitatively mea-
sured by lactate dehydrogenase (LDH) release. Aliquots (50 ml) of
cell culture medium were mixed with 0.42 mM b-NADH in
potassium phosphate buffer, pH 7.4 (125 ml; sigma) and 20 mM
sodium pyruvate (25 ml; Sigma) in a microplate. After being mixed
with sodium pyruvate, the samples were measured immediately 7
times at 340 nm for 5 min. Kinetic measurements were monitored
using a microplate spectrophotometer (PowerWave XS; BIO-
TEK instruments Inc., Winooski, VT). We used 0.5% Triton X-
100-treated samples as positive controls.
Western blot analysis
Harvested cell pellets were resuspended in RIPA buffer
(150 mM NaCl, 1% Nonidet P-40, 0.5% deoxycholic acid, 0.1%
SDS, and 50 mM Tris-HCl, pH 7.4) containing protease
inhibitors (Sigma) and incubated on ice for 20 min. After
centrifugation at 15,000 g for 20 min, the supernatant was
collected. Crude membrane fractions of the cultured cells were
prepared according to previous reports, with minor modifications
[32,33]. Protein concentrations were determined by BCA assay
(Sigma), and equal amounts of protein were loaded on appropriate
gels. The separated samples were transferred to a PVDF
membrane and incubated with antibodies against the target
proteins. Protein bands were visualized by enhanced chemilumi-
nescence (ECL; Amersham Pharmacia Biotech, Buckinghamshire,
England) using a bioimaging analyzer (LAS-3000; Fuji, Tokyo,
Japan).
ROS measurement
Levels of hydrogen peroxide were determined using dichloro-
fluorescein diacetate (DCFDA; Invitrogen, Carlsbad, CA). Treat-
ed cells were incubated with 10 mM DCFDA for 30 min and
washed with PBS. Fluorescent signals were captured using a
fluorescence microscope (Olympus, Tokyo, Japan).
Immunofluorescence
Treated cells were fixed with 2% paraformaldehyde (PFA) for
10 min and washed with PBS. Fixed cells were permeabilized with
PBST buffer (0.5% Triton X-100 in PBS) and incubated with
blocking solution (2% goat serum and 2% horse serum in PBST)
for 1 hr. Cells were incubated with primary antibodies in blocking
solution overnight at 4uC. Labeled cells were washed with PBST
and relabeled with Cy-3-conjugated secondary antibody. After
cells were counterstained with DAPI (Sigma), fluorescent signals
were visualized by fluorescence microscopy (Olympus).
Statistical analysis
All data were expressed as mean6SEM. Significant differences
were calculated using one-way ANOVA with Tukey’s post-test. A
P value of less than 0.05 denoted a statistically significant
difference.
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